Our results point towards a link between low BRAF V600 expression and a better immune response mediated by a BRAF V600-induced senescence-like phenotype, where the OIS acts as a tumor suppressor through the upregulation of antigen presentation and interferon-gamma signaling, thus improving patient outcomes. The gene discussed is IFNG; the disease is neoplasm.